Advantage Investment Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $9K | Hold |
3,000
| – | – | 0.01% | 659 |
|
|
2019
Q2 | $10K | Hold |
3,000
| – | – | 0.01% | 653 |
|
|
2019
Q1 | $9K | Hold |
3,000
| – | – | 0.01% | 660 |
|
|
2018
Q4 | $5K | Hold |
3,000
| – | – | ﹤0.01% | 782 |
|
|
2018
Q3 | $8K | Hold |
3,000
| – | – | 0.01% | 744 |
|
|
2018
Q2 | $8K | Hold |
3,000
| – | – | 0.01% | 677 |
|
|
2018
Q1 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 705 |
|
|
2017
Q4 | $10K | Buy |
3,000
+2,000
| +200% | +$6.67K | ﹤0.01% | 679 |
|
|
2017
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 841 |
|
|
2017
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 825 |
|
|
2017
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 771 |
|
|
2016
Q4 | $4K | Buy |
1,000
+500
| +100% | +$2K | ﹤0.01% | 767 |
|
|
2016
Q3 | $2K | Buy |
+500
| New | +$2K | ﹤0.01% | 816 |
|